What is the first line of treatment for leucoma (corneal opacity)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment for Leucoma (Corneal Opacity)

Phototherapeutic keratectomy (PTK) is the first-line treatment for leucoma when the corneal opacity is limited to the anterior 10-15% of stromal thickness. 1

Treatment Algorithm Based on Depth of Opacity

For Superficial Opacities (Anterior 10-15% of Cornea)

  1. Phototherapeutic Keratectomy (PTK)

    • Most beneficial for anterior stromal scarring 1
    • Provides rapid visual rehabilitation with improvement in best-corrected visual acuity (BCVA) 1
    • Can be combined with refractive treatment to reduce astigmatism 1
  2. Epithelial Debridement

    • For lesions anterior to Bowman layer 1
    • Performed with a lid speculum and microblade
    • Often followed by bandage contact lens and prophylactic antibiotics
  3. Mitomycin-C Application

    • Used as adjunct to prevent recurrence of scarring 1
    • Typically applied at 0.02% concentration using a wet cellulose disk 1
    • Requires careful irrigation afterward to prevent toxicity

For Deeper Opacities

  1. Superficial or Anterior Lamellar Keratectomy

    • For deeper but not full-thickness opacities
    • Can be combined with PTK for better outcomes 1
    • Best-corrected visual acuity significantly improves at 2,6, and 12 months 1
  2. Keratoplasty (Corneal Transplantation)

    • For opacities involving mid and deep stroma 1
    • Options include:
      • Deep anterior lamellar keratoplasty (DALK)
      • Penetrating keratoplasty (PK)

Special Considerations

For Band Keratopathy

  • Use disodium EDTA to facilitate calcium removal 1
  • Apply using cellulose sponge or sterile cotton applicator soaked in 3-4% solution 1

For Cosmetic Concerns

  • Corneal Tattooing can be considered for non-visual improvement 1
  • Involves embedding sterile India ink or carbon particles in anterior/mid stroma 1
  • Has shown satisfactory cosmetic results with minimal complications 2, 3

For Severe Cases with Poor Visual Potential

  • Keratoprosthesis may be considered when traditional treatments fail 4
  • Particularly useful in cases with:
    • Severe vascularization
    • Recurrent transplant rejections
    • Leucoma adherens

Potential Complications and Management

PTK Complications

  • Post-treatment haze and hyperopia with deeper treatments
  • Recurrence of underlying disease
  • Surface irregularity
  • Risk of infectious keratitis

Prevention of Complications

  • Masking agents (methylcellulose or sodium hyaluronate) during PTK to create smooth surface 1
  • Mitomycin-C to reduce haze and recurrence 1
  • Bandage contact lenses and prophylactic antibiotics after procedures 1
  • Antiviral prophylaxis if history of herpetic eye disease 1

Follow-up and Monitoring

  • Assess visual acuity improvement
  • Monitor for recurrence of opacity
  • Evaluate corneal transparency, regularity, and optical quality 1
  • Consider rigid gas permeable (RGP) contact lenses for residual surface irregularity 1

The treatment approach should be guided by the depth and extent of the leucoma, with PTK being the preferred first-line option for superficial opacities due to its effectiveness in improving visual outcomes while being less invasive than keratoplasty.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Keratoprostheses. Clinical aspects].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.